Constantin Coussios is the Director of the Oxford Institute of Biomedical Engineering.  He received his BS, MEng and PhD in Engineering from the University of Cambridge, was a tutorial fellow in engineering at Magdalen between 2004 and 2010 and was elected to the first statutory chair in Biomedical Engineering at the University of Oxford in 2011, with special responsibility for drug delivery and therapeutic devices.

Together with Professor Peter Friend he was founder of the Oxford University spin-out OrganOx Ltd., which has developed a novel normothermic perfusion device for improved liver and kidney preservation prior to transplantation through to first-in-man trials and first sales.  In 2014, he co-founded OxSonics Ltd., which is developing a new generation of ultrasound-based medical devices for drug delivery and minimally invasive surgery,  and in 2016 he co-founded OrthoSon Ltd,  which is developing minimally invasive replacement of the intervertebral disc. In 2017, he received the Silver Medal of the UK’s Royal Academy of Engineering for his contributions to organ preservation and ultrasound-enhanced drug delivery. In 2019, he was elected a Fellow of the Royal Academy of Engineering.